Company Filing History:
Years Active: 2025
Title: Chetna Sharon: Innovator in Anti-Cancer Research
Introduction
Chetna Sharon is a prominent inventor based in Richmond, VA (US). She has made significant contributions to the field of cancer research, particularly in developing innovative therapeutic agents. Her work focuses on creating compounds that selectively target cancer stem cells, which are often resistant to conventional treatments.
Latest Patents
Chetna Sharon holds 1 patent for her invention titled "Lipidic analogs of anti-cancer stem cell agent." This patent describes a group of specific sulfated flavonoid agents that carry cholesterol modifications. These compounds exhibit promising in vivo anti-cancer activity through the selective inhibition of cancer stem cells, while sparing adult or hematopoietic stem cells. The agents demonstrate high potency, excellent oral bioavailability, and a physiologically relevant therapeutic window.
Career Highlights
Chetna is affiliated with Virginia Commonwealth University, where she conducts her research and develops her innovative solutions. Her work has garnered attention for its potential to revolutionize cancer treatment by targeting the root causes of cancer resistance.
Collaborations
Chetna collaborates with esteemed colleagues, including Umesh R Desai and Balaji Nagarajan, to further her research and enhance the impact of her inventions.
Conclusion
Chetna Sharon's contributions to anti-cancer research exemplify the power of innovation in addressing complex medical challenges. Her work not only advances scientific understanding but also holds the potential to improve patient outcomes in cancer treatment.